T2 Biosystems director sells shares worth $133 | news.google.com • |
T2 Biosystems stock hits 52-week low at $2.26 amid steep decline | news.google.com • |
T2 Biosystems Receives FDA Clearance to Market the T2Candida Panel for Pediatric Patients | news.google.com • |
T2 Biosystems to Participate in the H.C. Wainwright 26th Annual Global Investment Conference | globenewswire.com • |
T2 Biosystems to Attend Upcoming Investor Conferences | globenewswire.com • |
T2 Biosystems, Inc. (TTOO) Q2 2024 Earnings Call Transcript | seekingalpha.com • |
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-11-12 | 2024-09 | 0 | N/A | N/A | N/A |
2024-07-29 | 2024-06 | 0 | -0.66 | N/A | N/A |
2024-05-06 | 2024-03 | 0 | -2.66 | N/A | N/A |
2023-11-14 | 2023-09 | 0 | -3.45 | N/A | N/A |
2023-08-07 | 2023-06 | 0 | -8 | N/A | N/A |
2023-05-23 | 2023-03 | 0 | -117 | N/A | N/A |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2023-10-17 | ADAMS LAURA LEE | Director | 37.00 | Conversion of Exercise of derivative security |
2023-09-14 | BERNARD THIERRY | Director | 7.32K | Conversion of Exercise of derivative security |
2024-05-08 | CR GROUP, L.P. | Beneficial Owner of more than 10% of a Class of Security | 0.00 | Conversion of Exercise of derivative security |
2023-09-14 | CUMMING JOHN W | Director | 5.26K | Conversion of Exercise of derivative security |
2024-09-12 | ELSBREE DAVID B | Director | 25.00 | Sale |
2024-02-22 | GIBBS MICHAEL TERRENCE | General Counsel | 135.00 | Conversion of Exercise of derivative security |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Gsa Capital Partners Llp | 40.35K | 284.88K | 0.01% |
Split | Date |
---|---|
1 : 100 | 2023-10-13 |
1 : 50 | 2022-10-13 |
-
Fuck this Iām gone
-
Why is ask .33 and bid .36 but price at .30
-
Why
-
Fuckkkkkk
-
Why is this going down again I have lost over $4k listening to people in a month can I get a fucking break here
-
The fda approval will put this in compliance I think news will come after hours Friday night.
-
Letās make this thing halt going uptrend then fly
-
Letās gooo push past.40 open at .50
-
You are correct they proved that they have capability to go above $1 and show increases in revenue for them to allow another extension
-
Opening at .50+++
-
I sold at .40 and bought back with more shares at .36
-
We going to a $1 today
-
I have a hard time just being patient
-
I bought this stock at 10 cents then sold because it was not moving like 5 days ago ļøļø
-
Hold for the gold
-
Now on yo .45
-
Breaking 41 soon
-
Now next .50
-
Break .40 and itās to the moon
-
Iām all in
-
T2 Biosystems director sells shares worth $133
news.google.com • -
T2 Biosystems stock hits 52-week low at $2.26 amid steep decline
news.google.com • -
T2 Biosystems to Attend Upcoming Investor Conferences
globenewswire.com • -
T2 Biosystems, Inc. (TTOO) Q2 2024 Earnings Call Transcript
seekingalpha.com • -
T2 Biosystems Regains Compliance with Nasdaq Continued Listing Requirements
globenewswire.com • -
T2 Biosystems Announces CRG's Conversion from Preferred Stock to Common Stock
globenewswire.com • -
T2 Biosystems, Inc. (TTOO) Q1 2024 Earnings Call Transcript
seekingalpha.com • -
T2 Biosystems Announces First Quarter 2024 Financial Results
globenewswire.com • -
T2 Biosystems Announces Commercial Expansion Through Middle East Distributor
globenewswire.com • -
T2 Biosystems Shareholders Vote for CRG Debt Conversion into Equity
globenewswire.com •